A Nationwide, Multicenter, Retrospective Study of Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 18 Apr 2017 New trial record